Thursday 19 November 2026 Sign in / SubscribeFree daily emailMarket analysisEnterprise solutionsVigiEye regulatory newsCompePharma CRM & HR →
The business of pharma
Manufacturing & supply

FDA logs recall of Victory Medical Center Pharmacy semaglutide-carnitine vials in three states

An enforcement-report entry shows a pharmacy-supplied semaglutide and L-carnitine multi-dose product is being withdrawn, but it gives no volumes, so the commercial impact cannot be sized.

11 Nov 2026 · FDA enforcement report · Regulator

A semaglutide and L-carnitine injection supplied by Victory Medical Center Pharmacy is the subject of a recall entered in the US Food and Drug Administration's enforcement report dated 11 November 2026. The record carries the reference D-0139-2027 and shows the action as still open.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on CompePharma and VigiEye
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official record: FDA enforcement report ↗

Written by CompePharma's editorial system from the official record. AI-assisted; check the source before acting. Not investment advice.

More Manufacturing & supplyAll →